| Literature DB >> 31054104 |
Hannah McCann1,2, Giampaolo Pisano3, Leandro Beltrachini3,4.
Abstract
Electromagnetic source characterisation requires accurate volume conductor models representing head geometry and the electrical conductivity field. Head tissue conductivity is often assumed from previous literature, however, despite extensive research, measurements are inconsistent. A meta-analysis of reported human head electrical conductivity values was therefore conducted to determine significant variation and subsequent influential factors. Of 3121 identified publications spanning three databases, 56 papers were included in data extraction. Conductivity values were categorised according to tissue type, and recorded alongside methodology, measurement condition, current frequency, tissue temperature, participant pathology and age. We found variation in electrical conductivity of the whole-skull, the spongiform layer of the skull, isotropic, perpendicularly- and parallelly-oriented white matter (WM) and the brain-to-skull-conductivity ratio (BSCR) could be significantly attributed to a combination of differences in methodology and demographics. This large variation should be acknowledged, and care should be taken when creating volume conductor models, ideally constructing them on an individual basis, rather than assuming them from the literature. When personalised models are unavailable, it is suggested weighted average means from the current meta-analysis are used. Assigning conductivity as: 0.41 S/m for the scalp, 0.02 S/m for the whole skull, or when better modelled as a three-layer skull 0.048 S/m for the spongiform layer, 0.007 S/m for the inner compact and 0.005 S/m for the outer compact, as well as 1.71 S/m for the CSF, 0.47 S/m for the grey matter, 0.22 S/m for WM and 50.4 for the BSCR.Entities:
Keywords: Electrical impedance tomography; Electroencephalography; Electromagnetic source localisation; Head conductivity; Magnetic resonance electrical impedance tomography; Magnetoencephalography
Mesh:
Year: 2019 PMID: 31054104 PMCID: PMC6708046 DOI: 10.1007/s10548-019-00710-2
Source DB: PubMed Journal: Brain Topogr ISSN: 0896-0267 Impact factor: 3.020
Methodology strengths and limitations
| Method | Strengths | Limitations |
|---|---|---|
| DAC | - No computational head model required - Potential to classify all tissue types - Portable - Cost effective - Low acquisition time | - Invasive - Unnatural conditions if not in vivo - Homogeneous |
| EIT | - Non-invasive - In vivo - Portable - Cost effective - Low acquisition time | - Computational head model required - Low spatial resolution - Low signal-to-noise - Homogeneous |
| E/MEG | - non-invasive - in vivo - portable - cost effective - low acquisition time | - Computational head model required - Low spatial resolution - homogeneous |
| MREIT | - Non-invasive - In vivo - High spatial resolution - Anisotropic | - Low signal-to-noise ratio - Weak MR signal in skull layers - Non-portable - Relatively expensive - High acquisition time |
| DTI | - Non-invasive - In vivo - High spatial resolution - Anisotropic - Heterogeneous | - Non-portable - Relatively expensive - Weak MR signal in skull layers - High acquisition time |
Fig. 1Figure displaying the various tissue compartments of the head and a subfigure of the detailed layers of the scalp, skull and brain
Summary of papers included in meta-analysis
| Author | Method | Design | Freq. (Hz) | Participants | Age (years) | Pathology | Weight |
|---|---|---|---|---|---|---|---|
| (Burger and van Milaan | DAC | Ex vivo | 0 | n = 1 | Adult | Healthy | 0.799 |
| (Rosenthal and Tobias | DAC | Ex vivo | 1000 | n = 1 | Adult | Healthy | 0.361 |
| (Burger and Van Dongen | DAC | Ex vivo | 1000 | n = 1 | Adult | Healthy | 0.444 |
| (Rush and Driscoll | DAC | Ex vivo | n = 1 | Adult | Healthy | 0.833 | |
| (Cohen and Cuffin | E/MEG | In vivo | 0.3–300 | n = 2 (m) | Adult | Healthy | 0.705 |
| (Eriksen | E/MEG | In vivo | 40 | n = 4 | Adult | Healthy | 0.221 |
| (Haacke et al. | MREIT | In vivo | n = 3 | Adult | Healthy | 0.852 ± 0.02 | |
| (Law | DAC | In vitro | 100 | n = 1 | Adult | Healthy | 0.8723 |
| (Pierpaoli et al. | DTI | In vivo | n = 8 | Adult | Healthy | 0.344 | |
| (Baumann et al. | DAC | In vitro | 10–10 kHz | n = 7 (3 m) | 6.6 | Neuro | 0.69 ± 0.051 |
| (Sorensen et al. | DTI | In vivo | n = 1 | Adult | Stroke | 0.814 | |
| (Uluğ and Van Zijl | DTI | In vivo | n = 5 | Adult | Healthy | 0.375 | |
| (Oostendorp et al. | DAC | In vitro | 10–100 | n = 1, n = 2 (1 m) | Adult | Healthy | 0.768 |
| (Akhtari et al. | DAC | In vitro | 20 | n = 1 | Adult | Healthy | 0.855 |
| (Akhtari et al. | DAC | Ex vivo | 10, 90 | n = 4 (2 m) | 56 ± 26.7 | Epilepsy | 0.931 |
| (Hoekema et al. | DAC | In vitro, ex vivo | 10 | n = 1 (f), n = 5 | 68, 33.6 ± 15.9 | Healthy | 0.855 |
| (Goncalves et al. | EIT | In vivo | 60 | n = 6 (3 m) | 32.3 ± 7 | Healthy | 0.62 |
| (Goncalves et al. | EIT & E/MEG | In vivo | 60 | n = 6 (3 m) | Adult | Healthy | 0.496 ± 0.006 |
| (Baysal and Haueisen | E/MEG | In vivo | 4 | n = 10 (5 m) | 30 ± 13 | Healthy | 0.365 ± 0.368 |
| (Gutierrez et al. | E/MEG | In vivo | 2 | n = 2 (1 m) | 32.5 ± 10.6 | Healthy | 0.52 ± 0.08 |
| (Clerc et al. | EIT | In vivo | 110 | n = 1 | Adult | Healthy | 0.639 ± 0.009 |
| (Sekino et al. | DTI | In vivo | n = 5 | Adult | Healthy | 0.672 ± 0.02 | |
| (Lai et al. | EIT | In vivo | 50 | n = 5 (4 m) | 10 ± 2 | Epilepsy | 0.544 |
| (Zhang et al. | EIT | In vivo | 50 | n = 2 | Paediatric | Epilepsy | 0.656 |
| (Akhtari et al. | DAC | Ex vivo | 5–1005 | n = 21 (12 m) | 13.5 ± 15.1 | Epilepsy | 0.946 |
| (Tang et al. | DAC | In vitro | 1 kHz | n = 48 (38 m) | 47.6 | Healthy | 0.999 |
| (Gattellaro et al. | DTI | In vivo | n = 20 (10 m) | 60.95 ± 11.9 | Healthy, PD | 0.344 | |
| (Rullmann et al. | DTI | In vivo | n = 1 | 0.916 | Epilepsy | 0.975 | |
| (Voigt et al. | MREIT | In vivo | n = 1 | Adult | Healthy | 0.578 ± 0.067 | |
| (Akhtari et al. | DAC | Ex vivo | 6–1005 | n = 15 (8 m) | 7.93 ± 6.04 | Epilepsy | 0.946 |
| (Van Lier et al. | MREIT | In vivo | n = 1 | 46 | Tumour | 0.559 ± 0.014 | |
| (Güllmar et al. | DTI | In vivo | n = 1 (m) | 30 | Healthy | 0.406 | |
| (Wang et al. | DTI | In vivo | n = 71(39 m) | 41.8 ± 14.5 | Healthy | 0.375 | |
| (Dannhauer et al. | E/MEG | In vivo | n = 4 | 25 ± 4.6 | Healthy | 0.34 | |
| (Voigt et al. | MREIT | In vivo | n = 6 (m) | 37 ± 6 | Healthy | 0.846 ± 0.042 | |
| (van Lier et al. | MREIT | in vivo | n = 1 | 65 | Stroke | 0.475 | |
| (Huhndorf et al. | MREIT | In vivo | n = 12 | Tumour | 0.517 ± 0.259 | ||
| (Zhang et al. | MREIT | In vivo | n = 3 | Adult | Healthy | 0.731 | |
| (Aydin et al. | E/MEG | In vivo | n = 1 (f) | 17 | Epilepsy | 0.86 | |
| (Kim et al. | MREIT | In vivo | n = 1 | Adult | Healthy | 0.805 ± 0.117 | |
| (Ouypornkochagorn et al. | EIT | In vivo | n = 1 | Adult | Healthy | 0.774 ± 0.01 | |
| (Lee et al. | MREIT | In vivo | n = 2 | Adult | Healthy | 0.787 | |
| (Ropella and Noll, | MREIT | In vivo | n = 4 | Adult | Healthy | 0.028 ± 0.052 | |
| (Dabek et al. | EIT | In vivo | 2 | n = 9 (4 m) | 32.5 ± 10 | Healthy | 0.627 ± 0.037 |
| (Akhtari et al. | DAC | In vitro | 10 | n = 24 | Paediatric | Epilepsy | 0.698 ± 0.212 |
| (Acar et al. | E/MEG | In vivo | n = 2 (m) | 21.5 ± 2.12 | Healthy | 0.718 ± 0.019 | |
| (Gurler and Ider | MREIT | In vivo | n = 1 | 23 | Healthy | 0.817 ± 0.218 | |
| (Lee et al. | MREIT | In vivo | n = 1 | Adult | Healthy | 0.561 ± 0.382 | |
| (Koessler et al. | EIT | In vivo | 50 | n = 15 (10 m) | 38 ± 10 | Epilepsy | 0.643 ± 0.0478 |
| (Huang et al. | EIT | In vivo | 1–100 | n = 10 | Adult | Epilepsy | 0.613 |
| (Fernández-Corazza et al. | EIT | In vivo | 27 | n = 4 (m) | 49 ± 4.8 | Healthy | 0.593 ± 0.078 |
| (Hampe et al. | MREIT | In vivo | n = 4 | 39.5 ± 3.4 | Healthy | 0.406 | |
| (Arumugam et al. | EIT | In vivo | 27 | n = 10 | Healthy | 0.292 | |
| (Michel et al. | MREIT | In vivo | n = 1 | 29 | Healthy | 0.89 ± 0.028 | |
| (Tha et al. | MREIT | In vivo | n = 30 (14 m) | 50.7 ± 18.2 | Tumour | 0.486 | |
| (Chauhan et al. | DTI | In vivo | 10 | n = 2 (m) | Healthy | 0.939 |
Method: DC direct current, EIT electrical impedance tomography, E/MEG electro- or magneto-encephalography, MREIT magnetic resonance EIT, DTI diffusion tensor imaging. Frequency (Hz, unless stated otherwise. Participants: number (n =), male/female (m/f). Age: mean ± standard deviation, unless stated otherwise. Pathology: neurological disorder (neuro), Parkinson’s Disease (PD). Weight: mean ± standard deviation
Descriptive statistics for each tissue type
| Minimum | Maximum | Mean | Weighted mean | Standard deviation | n. values | n. studies | n. participants | |
|---|---|---|---|---|---|---|---|---|
| Scalp | 0.137 | 2.1 | 0.5345 | 0.4137 | 0.1760 | 44 | 10 | 44 |
| Fat | 0.6 | 1 | 1 | 1 | ||||
| Muscle | 0.1482 | 0.4167 | 0.3243 | 0.3243 | 0.1526 | 3 | 1 | 1 |
| Whole skull | 0.0182 | 1.718 | 0.0708 | 0.0160 | 0.019 | 99 | 20 | 121 |
| Spongy | 0.0012 | 0.2890 | 0.0559 | 0.0497 | 0.0735 | 18 | 5 | 58 |
| Compact | 0.0024 | 0.0079 | 0.0045 | 0.0046 | 0.0016 | 9 | 4 | 54 |
| Outer compact | 0.0008 | 0.0078 | 0.0047 | 0.0049 | 0.0029 | 10 | 2 | 5 |
| Inner compact | 0.0028 | 0.0129 | 0.0067 | 0.0068 | 0.0036 | 10 | 2 | 5 |
| Sutures | 0.0078 | 0.0735 | 0.0273 | 0.0266 | 0.0239 | 6 | 2 | 49 |
| CSF | 1 | 2.51 | 1.6922 | 1.71 | 0.2981 | 43 | 14 | 37 |
| Whole brain | 0.054 | 13.75 | 1.059 | 0.3746 | 0.1322 | 63 | 11 | 70 |
| GM | 0.06 | 2.47 | 0.5981 | 0.4660 | 0.2392 | 66 | 16 | 153 |
| WM | 0.0646 | 0.81 | 0.24 | 0.2167 | 0.1703 | 104 | 15 | 106 |
| WM_perp | 0.0620 | 0.4390 | 0.1216 | 0.1175 | 0.0495 | 41 | 3 | 49 |
| WM_par | 0.0543 | 0.9150 | 0.1352 | 0.1226 | 0.0929 | 41 | 3 | 49 |
| Blood | 0.433 | 07622 | 0.5799 | 0.5737 | 0.106 | 14 | 3 | 3 |
| EZ | 0.2320 | 0.5278 | 0.2994 | 0.2949 | 0.0737 | 15 | 1 | 15 |
| Dura | 0.461 | 1 | 1 | 2 | ||||
| Cerebellum | 0.391 | 0.635 | 0.5415 | 0.5370 | 0.1141 | 4 | 1 | 1 |
| Lesions | 0.1 | 1.77 | 0.8087 | 0.8757 | 0.3772 | 19 | 5 | 45 |
| BSCR | 17.9 | 290 | 58.69 | 50.4 | 38.93 | 51 | 10 | 47 |
Spongiform (Spongy) and Compact (Inner and Outer Compact) of the skull layer, CSF cerebrospinal fluid, GM grey matter, WM white matter, BSCR brain-scalp conductivity ratio, number of… (n.)
Fig. 2Boxplot displaying the inter-quartile range (first to third quartile as solid box), the median (solid blue line), minimum and maximum (solid whiskers) of all available conductivity values (S/m) for all tissues and BSCR displayed as crosses
Fig. 3Boxplot displaying the mean value of the assigned weights for each study (indicated by a cross) dependent on the employed methodology
Fig. 4Boxplot displaying inter-quartile range (box), medium (solid blue horizontal line), maximum and minimum (upper and lower whiskers respectively) of scalp conductivity according to method for each available paper. Size of data points indicates relative weight of value
Fig. 5Boxplot displaying variation in whole-skull conductivity according to method
Fig. 6Boxplot displaying variation in conductivity of the spongiform bone layer of the skull according to condition
Fig. 7Boxplot displaying variation in conductivity of the compact layers according to condition
Fig. 8Boxplot displaying variation in CSF conductivity depending on method
Fig. 9Boxplot displaying variation in whole-brain conductivity depending on method
Fig. 10Boxplot displaying variation in GM conductivity depending on method
Fig. 11Boxplot displaying variation in GM conductivity depending on pathology (AD Alzheimer’s disease, PD Parkinson’s disease)
Fig. 12Boxplot displaying variation in WM conductivity according to method
Fig. 13Boxplot displaying variation in BSCR depending on method
Fig. 14Scatter diagram displaying BSCR as a function of participant’s age
| Item 1: Were participants appropriately recruited and described? | |
| Pre-specified protocol | No participant demographics or pathology were excluded in order to explore how variations affect conductivity values. However, both should be considered when analysing results to accurately determine their impact. Therefore, an accurate description of participants should be provided in order to appropriately group them for analysis. In the case no information is provided, it should be made clear participants are assumed to be healthy adults. |
| Yes-1 | At minimum, participant pathology was provided. Age is further included in the current meta-analysis if available. |
| No-0 | No information on participant pathology or demographics were provided, or sufficient to assume participants were healthy adults. |
| Unclear-0.5 | When no detailed description was available, it is still sufficient to assume participants were healthy adults. |
| Item 2: Does the measurement method appropriately determine the desired value? | |
| Pre-specified protocol | The study measures what they set out to measure (i.e. conductivity/resistivity) and reports the values appropriately. |
| Yes-1 | Results were reported in accordance to the study aims and methodology. |
| No-0 | Reported values were inconsistent with the study aims and what they claimed to report. |
| Unclear-0.5 | It is unclear whether or not reported results were in line with the studies aim, therefore an average of 0.5 for this item is assigned. |
| Item 3: Is the methodology accurately described such that it can be replicated? | |
| Pre-specified protocol | Employed methodology should be sufficiently described in order to accurately assess variation in conductivity values due to methodological differences. Enough information should therefore, at minimum, be provided to assign methodology. In order to further validate the chosen method, a sufficient description should allow replication of the method. |
| Yes-1 | Sufficient information was provided to assign a methodology and replicate their chosen method. |
| No-0 | No information was provided, and the review is unable to appropriately assign chosen methodology. |
| Unclear 0.5 | It is unclear whether enough information is provided for replication, but methodology can be assigned appropriately. |
| Item 4: Is the chosen methodology justified? | |
| Pre-specified protocol | As there are many different methods measuring conductivity, it would be expected each study would justify their chosen methodology, potentially based on the previous literature. |
| Yes-1 | Justification for the chosen method was provided. |
| No-0 | No justification for the employed methodology was provided. |
| Unclear-0.5 | It is unclear whether or not justification was provided, therefore an average of 0.5 for this item is assigned. |
| Item 5: Was the measurement protocol verified for accuracy? | |
| Pre-specified protocol | Tests measuring conductivity do not come without errors, in order to improve validity of the method, measurement errors should be provided to further verify their results. This may be through simulation or phantom experiments, or as standard deviations within each participant. |
| Yes-1 | The error associated with the chosen methodology was reported—from simulation, phantom or participant data. |
| No-0 | No protocol errors were reported. |
| Unclear-0.5 | It is unclear whether errors were reported or not—i.e. unclear whether reported errors were due to simulation, phantom or participant data errors. |
| Item 6: Did the measurement and verification method remain unchanged throughout the study? | |
| Pre-specified protocol | Methodology should remain constant throughout the measurement process, with any deviations described and justified. |
| Yes-1 | All measurements were obtained using the same methodology. |
| No-0 | Methodology did not remain constant. |
| Unclear-0.5 | It is unclear whether or not the methodology was consistent for each measurement, therefore an average of 0.5 for this item is assigned. |
| Item 7: Were the measurement errors within an acceptable range? Higher weight? | |
| Pre-specified protocol | Errors should be of an acceptable value otherwise use of the chosen method is not justified. Where errors are considerably large, a discussion should be made as to why and ramifications implemented. |
| Yes-1 | Errors were relatively low and within an acceptable range. |
| No-0 | Errors were considerably large, and no justifications/ramifications were made. |
| Unclear-0.5 | No clear error values were provided, or justification/ramification are absent/arbitrary, therefore an average of 0.5 for this item is assigned. |
| Item 8: Were measurements obtained immediately after tissue was excised? If no, how much time elapsed between excision and test? | |
| Pre-specified protocol | For conductivity values that reflect the most natural circumstances, measurements should be made immediately after tissue has been excised, or immediately after death. Time-elapsed from excision and measurements may affect the relative conductivity of the tissue. |
Yes-1 No: < 24 h-0.8 1–7 days-0.6 1–8 weeks-0.4 > 2 months-0.2 | No time elapsed from excision and test. Time elapsed between excision and test within the range described and an item score was assigned accordingly. |
| Unclear-0.5 | It was unclear how much time elapsed, therefore an average of 0.5 for this item is assigned. |
| Item 9: Were excised tissue samples kept in 100% saline? If no, what liquid (and concentration) were tissue samples kept in? | |
| Pre-specified protocol | To ensure conditions are kept as natural as possible, excised tissue should be contained within 100% saline, where conductivity is 1 S/m. |
| Yes-1 | Excised tissue samples were contained in 100% saline of 1 S/m conductivity. |
No: >90% saline-0.8 50–90% saline-0.6 < 50% saline-0.4 Dry-0.2 | Tissue samples were kept in varying concentrations of saline and quality scores were assigned accordingly. |
| Unclear-0.5 | It is unclear what concentration of saline tissues were kept in, hence they were assigned an average score of 0.5 |
| Item 10: Was the tissue kept at body temperature (~ 37 °C)? | |
| Pre-specified protocol | For conductivity values that reflect the most natural circumstances, excised tissue should be maintained at body temperature. |
| Yes-1 | Tissue kept at approximately body temperature (34–39 °C) |
| No-0 | Tissue not at body temperature. |
| Unclear-0.5 | The temperature of the tissue during conductivity measurements was unclear or ambiguous, therefore an average of 0.5 for this item was assigned. |
| Item 11: Is an individualised head model considered for each participant? | |
| Pre-specified protocol | Head shape and tissue thickness varies considerably between individuals; therefore, head models should be personalised for each individual – i.e. from MRI/DTI data. If not, realistic head models should be employed as opposed to a spherical model, as the head is not a simplistic sphere. Individualistic head models were considered. |
| Yes, individualistic-1 | A realistic head model was employed. |
| No, realistic-0.75 | A spherical head model was employed. |
No, spherical-0.25 Unclear-0.5 | The head model used was unclear, hence an average quality score of 0.5 is given. |
| Item 12: Has the head been maximally segmented into appropriate layers depending on the tissue type being measured? | |
| Pre-specified protocol | As specified by sub-sections: |
| 12a: scalp | |
Yes: muscle, fat skin- 1 Yes: 2 layers-0.5 | The scalp was segmented into the 3 tissue layers of muscle, fat, skin |
| No-0 | The scalp is considered as 2 layers (i.e. muscle + fat) |
| N/A | Scalp is considered one homogenous layer. If the study did not measure scalp conductivity, item 12a is not included in the Quality Assessment score. |
| 12b: skull | |
| Yes: four layers-1 | The skull was segmented into spongiform, inner and outer compact bone with sutures. |
| Yes: three layers-0.66 | Skull considered tri-layered; spongiform, inner and outer compact bone without sutures. |
| Yes: two layers-0.33 | Skull segmented into spongiform and compact bone. |
| No: one layer-0 | The skull was considered as one homogenous head layer. |
| N/A | If the study did not measure scalp conductivity, item 12b is not included in the Quality Assessment score. |
| 12c: brain | |
| Yes: GM + WM – 1 | The brain was compartmented into grey and white matter. |
| No: homogenous-0.5 | The brain was considered as a homogenous tissue. |
| No: scalp = brain-0 | The brain was assumed to have the same conductivity as the scalp. |
| N/A | If the study did not measure brain conductivity, item 12c is not included in the Quality Assessment score. |
| 12d: WM anisotropy | |
| Yes: anisotropic-1 | WM was modelled as anisotropic |
| No- isotropic-0 | WM was modelled as isotropic, or this was not mentioned in the study, therefore WM was assumed to be modelled as isotropic |
| N/A | If the study did not measure WM conductivity, item 12d is not included in the Quality Assessment score. |
| Item 13: Were no assumptions made for the conductivity value of any tissue type? | |
| Pre-specified protocol | Conductivity values for all reported tissue types were empirically measured rather than assumed from prior literature (i.e. CSF is often assumed to model the remaining tissues). |
| Yes-1 | No assumptions were made |
| No-0 | Conductivity was assumed for one or more tissue types. |
| Item 14: Was the magnetic resonance resolution high? | |
| Pre-specified protocol | High resolution magnetic resonance imaging data with small voxel sizes should be acquired in order to most accurately segment head tissue and improve spatial resolution. |
| Yes: < 1 mm-1 | MR resolution is 1 mm3 or less. |
| No: 1–2 mm-0.8 | Resolution between 1 and 2 mm3. |
| No: 2–3 mm-0.6 | Resolution between 2 and 3 mm3. |
| No: 3–4 mm-0.4 | Resolution between 3 and 4 mm3. |
| No: > 4 mm-0.2 | Resolution above 4 mm3. |
| Unclear-0.5 | The resolution used was unclear or unprovided, hence an average quality score of 0.5 is given. |
| N/A | If the study did not employ a magnetic resonance method, item 14 is not included in the Quality Assessment score. |
| Item | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12a | 12b | 12c | 12d | 13 | 14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Score | 1 | 1 | 1 | 1 | 0 | 1 | 0.5 | 0.4 | 0.5 | 1 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total | 7.4 | ||||||||||||||||
| QAS | 0.74 (Score total divided by number of relevant items, in this case 10) | ||||||||||||||||
| Item | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12a | 12b | 12c | 12d | 13 | 14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Score | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0.2 | 0.8 | 1 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total | 9 | ||||||||||||||||
| QAS | 0.9 (Score total divided by number of relevant items, in this case 10) | ||||||||||||||||
| Item | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12a | 12b | 12c | 12d | 13 | 14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Score | 1 | 1 | 1 | 1 | 0 | 1 | 0.5 | N/A | N/A | N/A | 1 | 0 | 0.66 | 1 | N/A | 0 | N/A |
| Total | 8.16 | ||||||||||||||||
| QAS | 0.68 (Score total divided by number of relevant items, in this case 12) | ||||||||||||||||
| Item | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12a | 12b | 12c | 12d | 13 | 14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Score | 1 | 1 | 1 | 1 | 1 | 1 | 1 | N/A | N/A | N/A | 1 | 0 | 0.33 | 1 | N/A | 0 | N/A |
| Total | 9.33 | ||||||||||||||||
| QAS | 0.7775 (Score total divided by number of relevant items, in this case 12) | ||||||||||||||||
| Item | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12a | 12b | 12c | 12d | 13 | 14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Score | 1 | 1 | 1 | 1 | 1 | 1 | 1 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 1 |
| Total | 8 | ||||||||||||||||
| QAS | 1 (Score total divided by number of relevant items, in this case 8) | ||||||||||||||||
| Item | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12a | 12b | 12c | 12d | 13 | 14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Score | 1 | 1 | 1 | 1 | 1 | 1 | 0.5 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.8 |
| Total | 7.3 | ||||||||||||||||
| QAS | 0.9125 (Score total divided by number of relevant items, in this case 8) | ||||||||||||||||